Double maintains 1 strategies that include AVXL - Anavex Life Sciences Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -12.95% | $45.74M | -99.96% | 0.00% |
IMNN | -11.31% | $8.21M | -59.89% | 0.00% |
ED | -11.24% | $36.75B | +5.26% | 3.28% |
EVH | -11.18% | $1.04B | -62.16% | 0.00% |
CBOE | -9.51% | $22.95B | +20.67% | 1.12% |
HRB | -8.27% | $7.60B | +7.02% | 2.55% |
CME | -7.57% | $98.74B | +28.80% | 3.84% |
LFVN | -7.32% | $158.74M | +75.02% | 1.27% |
IMMP | -7.03% | $289.16M | -32.19% | 0.00% |
NEUE | -6.70% | $62.05M | +13.56% | 0.00% |
LITB | -6.45% | $21.28M | -72.45% | 0.00% |
WHF | -6.39% | - | - | 17.11% |
KO | -6.31% | $308.23B | +13.09% | 2.75% |
KR | -5.92% | $44.68B | +24.17% | 1.89% |
EBAY | -5.88% | $32.55B | +33.97% | 1.56% |
PULM | -4.98% | $23.82M | +239.64% | 0.00% |
PRPO | -4.69% | $10.84M | +15.14% | 0.00% |
VSA | -4.64% | $7.04M | -49.24% | 0.00% |
VHC | -4.61% | $34.69M | +74.89% | 0.00% |
AGL | -4.38% | $1.06B | -54.30% | 0.00% |
Yahoo
Key Insights The considerable ownership by individual investors in Anavex Life Sciences indicates that they...
SeekingAlpha
Does Anavex's Alzheimer's Drug Actually Confer Benefit?
SeekingAlpha
Discover how early use of Blarcamesine shows promise in treating Alzheimer's, boosting Anavex's potential.
Yahoo
Anavex Life Sciences Corp (AVXL) showcases strong financial health and advances in Alzheimer's and schizophrenia treatments, despite facing some developmental and regulatory challenges.
Yahoo
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ and H.C. Wainwright 6th Annual Neuro Perspectives ConferenceNEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous s
Yahoo
NEW YORK (AP) — Anavex Life Sciences Corp. AVXL) on Tuesday reported a loss of $11.2 million in its fiscal second quarter. On a per-share basis, the New York-based company said it had a loss of 13 cents.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -35.30% | $361.41M | 1.43% |
VIXY | -27.00% | $109.64M | 0.85% |
TAIL | -24.34% | $140.49M | 0.59% |
TFLO | -22.98% | $7.06B | 0.15% |
ULST | -14.12% | $637.77M | 0.2% |
IVOL | -12.00% | $353.94M | 1.02% |
TPMN | -11.56% | $31.54M | 0.65% |
BILZ | -10.37% | $876.85M | 0.14% |
SPTS | -10.17% | $5.76B | 0.03% |
XONE | -10.14% | $603.24M | 0.03% |
LDUR | -8.61% | $849.09M | 0.5% |
XBIL | -6.98% | $782.40M | 0.15% |
STPZ | -6.50% | $446.46M | 0.2% |
UTWO | -6.27% | $387.71M | 0.15% |
GBIL | -6.27% | $6.17B | 0.12% |
BIL | -6.21% | $45.95B | 0.1356% |
SMB | -6.17% | $269.10M | 0.07% |
CTA | -5.80% | $1.05B | 0.76% |
XHLF | -5.40% | $1.46B | 0.03% |
BILS | -5.32% | $3.96B | 0.1356% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 50.13% | $4.85B | 0.35% |
ARKG | 48.29% | $944.78M | 0.75% |
PTH | 45.62% | $96.56M | 0.6% |
IBB | 44.44% | $5.22B | 0.45% |
PBW | 44.19% | $269.08M | 0.65% |
IWC | 43.87% | $766.88M | 0.6% |
IWO | 43.65% | $11.36B | 0.24% |
GNOM | 42.50% | $40.65M | 0.5% |
PBE | 42.45% | $214.12M | 0.58% |
KOMP | 42.01% | $2.20B | 0.2% |
ARKX | 41.49% | $287.52M | 0.75% |
IWM | 41.43% | $63.95B | 0.19% |
PINK | 41.42% | $131.52M | 0.5% |
VTWO | 41.41% | $12.07B | 0.07% |
XPH | 41.11% | $136.58M | 0.35% |
ROBT | 40.98% | $462.06M | 0.65% |
ISCG | 40.50% | $645.00M | 0.06% |
VBK | 40.39% | $18.33B | 0.07% |
FBT | 40.32% | $994.71M | 0.56% |
SCHA | 39.89% | $16.91B | 0.04% |
Current Value
$8.441 Year Return
Current Value
$8.441 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RUM | 52.16% | $3.49B | +42.34% | 0.00% |
RXRX | 45.65% | $1.73B | -55.31% | 0.00% |
RAPT | 42.93% | $107.01M | -80.46% | 0.00% |
EYPT | 42.68% | $393.60M | -54.31% | 0.00% |
NNOX | 41.90% | $347.50M | -44.56% | 0.00% |
SYNA | 41.88% | $2.52B | -29.56% | 0.00% |
KYMR | 41.12% | $1.95B | -15.67% | 0.00% |
NTLA | 40.28% | $836.43M | -69.14% | 0.00% |
IDYA | 40.07% | $1.52B | -58.32% | 0.00% |
SDGR | 39.73% | $1.71B | +2.01% | 0.00% |
KN | 39.56% | $1.48B | -2.96% | 0.00% |
KALV | 38.77% | $579.68M | -3.40% | 0.00% |
XNCR | 38.61% | $583.60M | -63.49% | 0.00% |
PDSB | 38.58% | $61.66M | -61.76% | 0.00% |
COHU | 38.29% | $829.14M | -40.03% | 0.00% |
AEIS | 38.18% | $4.47B | +12.61% | 0.34% |
ABCL | 38.17% | $602.94M | -46.56% | 0.00% |
AI | 37.97% | $3.11B | -10.65% | 0.00% |
ROIV | 37.73% | $7.68B | -5.70% | 0.00% |
NVEC | 37.66% | $343.58M | -7.59% | 4.22% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CANE | 0.04% | $10.71M | 0.29% |
TDTT | 0.09% | $2.47B | 0.18% |
LMBS | 0.26% | $4.97B | 0.64% |
IBTL | -0.28% | $367.56M | 0.07% |
SCHO | -0.29% | $10.87B | 0.03% |
SPTI | -0.39% | $8.70B | 0.03% |
DFNM | -0.42% | $1.53B | 0.17% |
IBTP | 0.51% | $129.44M | 0.07% |
YEAR | -0.53% | $1.40B | 0.25% |
IBMN | 0.53% | $446.12M | 0.18% |
SHY | -0.55% | $24.03B | 0.15% |
JSI | 0.55% | $729.68M | 0.49% |
STIP | -0.59% | $11.88B | 0.03% |
CARY | -0.65% | $347.36M | 0.8% |
OWNS | 0.80% | $134.57M | 0.3% |
IEF | 0.88% | $34.17B | 0.15% |
BSV | -0.97% | $38.35B | 0.03% |
SHV | 0.98% | $20.94B | 0.15% |
TYA | -0.99% | $149.38M | 0.15% |
WEAT | -1.02% | $115.83M | 0.28% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
STG | -0.01% | $27.05M | -37.35% | 0.00% |
BF.B | 0.02% | $16.82B | -26.93% | 2.49% |
CCRN | -0.08% | $457.33M | -5.30% | 0.00% |
SANA | -0.09% | $385.70M | -80.00% | 0.00% |
AIFU | 0.15% | $9.85M | -95.03% | 0.00% |
QUAD | -0.18% | $290.01M | +15.76% | 3.91% |
MOH | -0.19% | $17.02B | -8.99% | 0.00% |
SO | 0.26% | $96.04B | +10.08% | 3.29% |
DUK | 0.26% | $90.12B | +12.74% | 3.61% |
DG | 0.26% | $20.45B | -36.56% | 2.55% |
SPTN | -0.26% | $657.97M | -7.52% | 4.49% |
GO | 0.39% | $1.37B | -35.98% | 0.00% |
BBDO | -0.42% | $12.93B | +12.38% | 1.50% |
TR | 0.44% | $2.37B | +11.85% | 1.10% |
VITL | -0.49% | $1.53B | -9.44% | 0.00% |
GHI | 0.52% | $272.58M | -23.91% | 12.67% |
MGPI | 0.58% | $689.42M | -59.90% | 1.47% |
SBS | 0.62% | $13.91B | +31.04% | 3.15% |
CLX | 0.66% | $16.64B | -1.45% | 3.61% |
CNC | -0.67% | $29.89B | -22.14% | 0.00% |